Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Denali Therapeutics
DNLI
$3.94B
| $5.67M | ﹤0.01% |
278,067
+22,184
| +9% | +$568K |
|
2027
Teradata
TDC
$2.55B
| $5.66M | ﹤0.01% |
181,808
+12,121
| +7% | +$379K |
|
2028
Virtu Financial
VIRT
$4.93B
| $5.66M | ﹤0.01% |
158,655
+103,169
| +186% | +$3.55M |
|
2029
Standard BioTools
LAB
$314M
| $5.65M | ﹤0.01% |
3,230,851
+2,491
| +0.1% | +$4.64K |
|
|
SWTX
2030
DELISTED
SpringWorks Therapeutics
SWTX
| $5.64M | ﹤0.01% |
156,123
+447
| +0.3% | +$15.6K |
|
2031
Kanzhun
BZ
$7.36B
| $5.63M | ﹤0.01% |
407,827
-42,836
| -10% | -$630K |
|
2032
Timken Company
TKR
$9.03B
| $5.62M | ﹤0.01% |
78,704
-7,963
| -9% | -$626K |
|
2033
PUT
Stryker
SYK
$130B
| $5.62M | ﹤0.01% |
15,600
| – | – |
|
2034
Expro Ltd
XPRO
$1.91B
| $5.61M | ﹤0.01% |
449,923
-23,569
| -5% | -$328K |
|
2035
Levi Strauss
LEVI
$9.39B
| $5.61M | ﹤0.01% |
324,182
+108,779
| +51% | +$1.93M |
|
2036
American Eagle Outfitters
AEO
$3.01B
| $5.61M | ﹤0.01% |
336,362
+38,099
| +13% | +$721K |
|
2037
Otter Tail
OTTR
$3.94B
| $5.59M | ﹤0.01% |
75,764
+5,211
| +7% | +$408K |
|
2038
Coeur Mining
CDE
$17.9B
| $5.58M | ﹤0.01% |
975,765
+13,113
| +1% | +$84.9K |
|
2039
Qfin Holdings
QFIN
$1.61B
| $5.58M | ﹤0.01% |
145,326
+38,593
| +36% | +$1.34M |
|
|
JHG
2040
DELISTED
Janus Henderson
JHG
| $5.58M | ﹤0.01% |
131,105
+34,888
| +36% | +$1.48M |
|
2041
Sonos
SONO
$1.85B
| $5.57M | ﹤0.01% |
370,614
-552,823
| -60% | -$7.44M |
|
2042
UGI
UGI
$7.33B
| $5.57M | ﹤0.01% |
197,392
-116,418
| -37% | -$3.02M |
|
2043
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $5.56M | ﹤0.01% |
74,454
+3,835
| +5% | +$292K |
|
2044
CALL
NetEase
NTES
$84.7B
| $5.55M | ﹤0.01% |
+62,200
| New | +$5.45M |
|
|
2045
PUT
NetEase
NTES
$84.7B
| $5.55M | ﹤0.01% |
+62,200
| New | +$5.45M |
|
2046
Sunstone Hotel Investors
SHO
$2.06B
| $5.55M | ﹤0.01% |
468,420
+125,402
| +37% | +$1.37M |
|
2047
Beazer Homes USA
BZH
$907M
| $5.53M | ﹤0.01% |
201,289
+10,548
| +6% | +$337K |
|
2048
Victory Capital Holdings
VCTR
$6.66B
| $5.53M | ﹤0.01% |
84,421
-14,946
| -15% | -$946K |
|
2049
Bausch + Lomb
BLCO
$5.99B
| $5.52M | ﹤0.01% |
305,804
+5,304
| +2% | +$104K |
|
2050
WaFd
WAFD
$2.75B
| $5.52M | ﹤0.01% |
171,258
+9,300
| +6% | +$327K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.